Expression of ezrin and phosphorylated ezrin (pezrin) in pancreatic ductal adenocarcinoma

Cancer Investigation

Volumn 28, Issue 3, 2010, Pages 242-247

  Cui, Yazhou ^a   Li, Tianliang ^a   Zhang, Denglu ^a   Han, Jinxiang ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Ezrin; Metastasis; Pancreatic cancer; Phosphorylation; Prognosis

Indexed keywords

EZRIN; PHOSPHOPROTEIN; PROTEIN KINASE B;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CYTOSKELETAL PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 77149179521     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900903124498     Document Type: Article

References (26)

1. Niggli, V.; Rossy, J. Ezrin/radixin/moesin: versatile controllers of signaling molecules and of the cortical cytoskeleton. Int J Biochem Cell Biol 2008, 40, 344-349.
2. Weng, W.H.; Ahlén, J.; Aström, K.; Lui, W.O.; Larsson, C. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 2005, 11, 6198-6204.
3. Zeng, H.; Xu, L.; Xiao, D.; Zhang, H.; Wu, X.; Zheng, R.; Li, Q.; Niu, Y.; Shen, Z.; Li, E. Altered expression of ezrin in esophageal squamous cell carcinoma. J Histochem Cytochem 2006, 54, 889-896.
4. Torer, N.; Kayaselcuk, F.; Nursal, T.Z.; Yildirim, S.; Tarim, A.; Nòyan, T.; Karakayali, H. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma. J Surg Oncol 2007, 96, 419-423.
5. Bal, N.; Yildirim, S.; Nursal, T.Z.; Bolat, F.; Kayaselcuk, F. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gas-troenterol 2007, 13, 3726-3729.
6. Kóbel, M.; Langhammer, T.; Hüttelmaier, S.; Schmitt, W.D.; Kriese, K.; Dittmer, J.; Strauss, H.G.; Thomssen, C.; Hauptmann, S. Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas. Mod Pathol 2006, 19, 581-587.
7. Kóbel, M.; Gradhand, E.; Zeng K.; Schmitt, W.D.; Kriese, K.; Lantzsch, T.; Wolters, M.; Dittmer, J.; Strauss, H.G.; Thomssen, C.; Hauptmann, S. Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. Int J Gynecol Pathol 2006, 25, 121-130.
8. Bruce, B.; Khanna, G.; Ren, L.; Landberg, G.; Jirstróm, K.; Powell, C.; Borczuk, A.; Keller, E.T.; Wojno, K.J.; Meltzer, P.; Baird, K.; McClatchey, A.; Bretscher, A.; Hewitt, S.M.; Khanna, C. Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis 2007, 24, 69-78.
9. Bretscher, A. Regulation of cortical structure by the ezrin-radixin-moesin protein family. Curr Opin Cell Biol 1999, 11, 109-116.
10. Barret, C.; Roy, C.; Montcourrier, P.; Mangeat, P.; Niggli, V. Mu-tagenesis of the phosphatidylinositol 4,5-bisphosphate (PIP(2)) binding site in the NH(2)-terminal domain of ezrin correlates with its altered cellular distribution. J Cell Biol 2000, 151, 1067-1080.
11. Brown, K.L.; Birkenhead, D.; Lai, J.C.; Li, L.; Li, R.; Johnson, P. Regulation of hyaluronan binding by F-actin and colocalization of CD44 and phosphorylated ezrin/radixin/moesin (ERM) proteins in myeloid cells. Exp Cell Res 2005, 303, 400-414.
12. Tran, Quang C.; Gautreau, A.; Arpin, M.; Treisman, R. Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes. EMBO J 2000, 19, 4565-4576.
13. Gautreau, A.; Poullet, P.; Louvard, D.; Arpin, M. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1999, 96, 7300-7305.
14. Maresso, A.W.; Deng, Q.; Pereckas, M.S.; Wakim, B.T.; Barbieri, J.T. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. Cell Microbiol 2007, 9, 97-105.
15. Maresso, A.W.; Baldwin, M.R.; Barbieri, J.T. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS. J Biol Chem 2004, 279, 38402-38408.
16. Jia, J.; Wang, Y.; Zhou, L.; Jin, S. Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells. Infect Immun 2006, 74, 6557-6570.
17. Amara, N.; Palapattu, G.S.; Schrage, M.; Gu, Z.; Thomas, G.V.; Dorey, F.; Said, J.; Reiter, R.E. Prostate stem cell antigen is over-expressed in human transitional cell carcinoma. Cancer Res 2001, 61, 4660-4665.
18. Yu, Y.; Khan, J.; Khanna, C.; Helman, L.; Meltzer, P.S.; Merlino, G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004, 10, 175-181.
19. Khanna, C.; Wan, X.; Bose, S.; Cassaday, R.; Olomu, O.; Mendoza, A.; Yeung, C.; Gorlick, R.; Hewitt, S.M.; Helman, L.J. The membrane-cytoskeleton linker ezrin isnecessary for osteosar-coma metastasis. Nat Med 2004, 10, 182-186.
20. Links Akisawa, N.; Nishimori, I.; Iwamura, T.; Onishi, S.; Hollingsworth, M.A. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun 1999, 258, 395-400.
21. Kocher, H.M.; Sandle, J.; Mirza, T.A.; Li, N.F.; Hart, I.R. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut 2009, 58, 271-284.
22. Sarrió, D.; Rodríguez-Pinilla, S.M.; Dotor, A.; Calero, F.; Hardisson, D.; Palacios, J. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res Treat 2006, 98, 71-79.
23. Yeh, T.S.; Tseng, J.H.; Liu, N.J.; Chen, T.C.; Jan, Y.Y.; Chen, M.F. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. Arch Surg 2005, 140, 1184-1190.
24. Krishnan, K.; Bruce, B.; Hewitt, S.; Thomas, D.; Khanna, C.; Helman, L.J. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway. Clin Exp Metastasis 2006, 23, 227-236.
25. Jiang, B.H.; Liu, L.Z. AKT signaling in regulating angiogenesis. Curr Cancer Drug Targets 2008, 8, 19-26.
26. Jiang, B.H.; Liu, L.Z. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 2008, 1784, 150-158.